Georges Gemayel

Insider Reports History

Entity
Individual
Location
550 Hills Drive, Bedminster, New Jersey
Signature
By: /s/ Rahul Khara, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Georges Gemayel:

Stock Role Class Num Shares Value Price $ Report Date Ownership
SUPERNUS PHARMACEUTICALS, INC. Director Common Stock 17.2K $500K $29.06 Feb 23, 2024 Direct
SUPERNUS PHARMACEUTICALS, INC. Director Restricted Stock Unit 0 $0 $29.06 Feb 23, 2024 Direct
Disc Medicine, Inc. Director Stock Option (Right to Buy) 10K Jun 12, 2024 Direct
SUPERNUS PHARMACEUTICALS, INC. Director Director Stock Option (Right to Buy) 8.25K Feb 22, 2024 Direct

Insider Reports Filed by Georges Gemayel

Symbol Company Period Transactions Value $ Form Type Date Filed Role
IRON Disc Medicine, Inc. Jun 12, 2024 1 $0 4 Jun 14, 2024 Director
SUPN SUPERNUS PHARMACEUTICALS, INC. Feb 23, 2024 2 $0 4 Feb 27, 2024 Director
SUPN SUPERNUS PHARMACEUTICALS, INC. Feb 22, 2024 2 $0 4 Feb 26, 2024 Director
IRON Disc Medicine, Inc. Jun 9, 2023 1 $0 4 Jun 9, 2023 Director
SUPN SUPERNUS PHARMACEUTICALS, INC. Feb 23, 2023 2 $0 4 Feb 27, 2023 Director
SUPN SUPERNUS PHARMACEUTICALS, INC. Feb 22, 2023 2 $0 4 Feb 24, 2023 Director
IRON Disc Medicine, Inc. Dec 29, 2022 1 $0 4 Jan 3, 2023 Director
SUPN SUPERNUS PHARMACEUTICALS, INC. Feb 22, 2022 2 $0 4 Feb 24, 2022 Director
SUPN SUPERNUS PHARMACEUTICALS, INC. Feb 19, 2022 2 $0 4 Feb 23, 2022 Director
IRON Gemini Therapeutics, Inc. /DE Jan 3, 2022 1 $0 4 Jan 5, 2022 Executive Chair of the Board, Director
IRON Gemini Therapeutics, Inc. /DE Nov 15, 2021 2 $0 4 Nov 16, 2021 Executive Chair of the Board of Directors, Director